Screener
Immunome IMNM Business Segments — General And Administrative Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: Immunome’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219425
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| IM-1617 | 838 | 375 |
| Other direct research and development | 9,971 | 4,673 |
| Indirect research and development(2) | 16,314 | 10,337 |
| General and administrative(3) | 8,649 | 7,376 |
| Other segment expenses(4) | 8,556 | 6,314 |
| Total operating expenses | 59,331 | 47,562 |
| Loss from operations | (59,331) | (44,636) |
| Interest income | 5,492 | 2,996 |
Item 1. Financial Statements.
FAQ
- What is Immunome's business segments — general and administrative expense?
- Immunome (IMNM) reported business segments — general and administrative expense of -$8.65M in Q1 2026.
- How has Immunome's business segments — general and administrative expense changed year-over-year?
- Immunome's business segments — general and administrative expense decreased by 17.3% year-over-year, from -$7.38M to -$8.65M.
- What is the long-term trend for Immunome's business segments — general and administrative expense?
- Over 2 years (2023 to 2025), Immunome's business segments — general and administrative expense has grown at a 63.4% compound annual growth rate (CAGR), from $19.66M to $52.46M.
- What does business segments — general and administrative expense mean?
- Covers the costs of supporting the business functions, including executive management, legal, finance, human resources, and other corporate overheads. This metric reflects the operational efficiency of the company's management structure and its ability to scale administrative support relative to its growth. High levels relative to revenue may indicate a need for improved operational leverage.
Ask your AI about Immunome's business segments — general and administrative expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude